Erratum to: The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?
Blumenthal, D. T., Mendel, L., Bokstein, F.Volume:
127
Journal:
Journal of Neuro-Oncology
DOI:
10.1007/s11060-016-2100-6
Date:
May, 2016
File:
PDF, 302 KB
2016